| | Identification | Back Directory |  | [Name] 
 ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2
 |  | [CAS] 
 90954-53-3
 |  | [Synonyms] 
 CGRPI
 CGRP (HUMAN)
 CGRP-I, HUMAN
 CGRP-1, HUMAN
 a-CGRP (huMan)
 α-CGRP (huMan)
 ALPHA-CGRP (HUMAN)
 α-CGRP (huMan)
CGRP-I (huMan)
 M.W. 3789.36    C163H267N51O49S2
 CGRP-I (HUMAN) TRIFLUOROACETATE SALT
 CALCITONIN GENE RELATED PEPTIDE HUMAN
 Human calcitonin gene-related peptide 1
 ALPHA-CGRP (HUMAN) TRIFLUOROACETATE SALT
 CALCITONIN GENE-RELATED PEPTIDE-I, HUMAN
 ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2
 α-CGRP (mouse, rat) trifluoroacetate salt
 α-Calcitonin gene-related peptide (human)
 ALPHA-CALCITONIN GENE RELATED PEPTIDE, HUMAN
 Calcitonin gene related peptide human, ≥95% (HPLC)
 α-CGRP (human)|Calcitonin Gene Related Peptide II, human
 ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 (DISULFIDE BRIDGE: 2-7)
 CalcitoninGeneRelatedPeptidehuMan,CalcitoninGeneRelatedPeptidehuMa
 ALPHA-CALCITONIN GENE-RELATED PEPTIDE (HUMAN) TRIFLUOROACETATE SALT
 Calcitonin Gene-Related Peptide-I, Human - CAS 90954-53-3 - Calbiochem
 ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2
 Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2
 H-ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2
 VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2: VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2
 ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2 USP/EP/BP
 ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2(CYS&CYS BRIDGE)
 H-ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2 (DISULFIDE BRIDGE: 2-7)
 ALA-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-MET-VAL-LYS-SER-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2(DISULFIDE BRIDGE CYS2-CYS7)
 Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 (Disulfide bridge Cys2-Cys7)
 Alpha-CGRP (human) trifluoroacetate salt H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 trifluoroacetate salt (Disulfide bond)
 |  | [Molecular Formula] 
 C163H267N51O49S2
 |  | [MDL Number] 
 MFCD00285485
 |  | [Molecular Weight] 
 3789.31
 | 
 | Chemical Properties | Back Directory |  | [storage temp. ] 
 −20°C
 
 |  | [solubility ] 
 5% acetic acid: 1mg/mL
 |  | [form ] 
 powder
 
 |  | [color ] 
 White to off-white
 |  | [Water Solubility ] 
 Soluble in water or 1% acetic acid at 1mg/ml.
 |  | [Sequence] 
 Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 (Disulfide bridge:Cys2-Cys7)
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 Calcitonin Gene Related Peptide is used as a potent, long-lasting vasodilator, activation of CGRP receptors on pancreatic β-cells increases plasma levels of pancreatic enzymes.
 |  | [Biochem/physiol Actions] 
 Potent, long-lasting vasodilator; activation of CGRP receptors on pancreatic β-cells increases plasma levels of pancreatic enzymes.
 |  | [in vivo] 
 
 α-CGRP(human) (Intravenous infusion; 0.03 nmol/kg/min; 60 min) can cause significant hypotension and tachycardia accompanied by falls in renal and mesenteric flows, but an increase in hindquarters flow, and a transient renal, sustained hindquarters vasodilatation and a mesenteric vasoconstriction in conscious rats[2]. |  | [storage] 
 Desiccate at -20°C
 | 
 |  |